Compare AMPH & BOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMPH | BOW |
|---|---|---|
| Founded | 1996 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 885.4M | 734.3M |
| IPO Year | 2005 | 2024 |
| Metric | AMPH | BOW |
|---|---|---|
| Price | $18.72 | $31.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | $28.38 | ★ $32.29 |
| AVG Volume (30 Days) | ★ 421.7K | 176.1K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.26 |
| EPS | 0.14 | ★ 0.48 |
| Revenue | ★ $719,887,000.00 | $551,589,000.00 |
| Revenue This Year | $6.90 | $21.31 |
| Revenue Next Year | $4.64 | $19.15 |
| P/E Ratio | $134.79 | ★ $61.56 |
| Revenue Growth | N/A | ★ 29.58 |
| 52 Week Low | $16.65 | $21.21 |
| 52 Week High | $31.26 | $33.01 |
| Indicator | AMPH | BOW |
|---|---|---|
| Relative Strength Index (RSI) | 44.70 | 57.14 |
| Support Level | $18.92 | $23.64 |
| Resistance Level | $19.99 | $32.83 |
| Average True Range (ATR) | 0.69 | 1.13 |
| MACD | -0.06 | -0.27 |
| Stochastic Oscillator | 27.58 | 54.63 |
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.
Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division, which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury, or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity, and hospitality segments, and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.